WO2001074386A3 - Cold-adapted equine influenza viruses - Google Patents
Cold-adapted equine influenza viruses Download PDFInfo
- Publication number
- WO2001074386A3 WO2001074386A3 PCT/US2001/008968 US0108968W WO0174386A3 WO 2001074386 A3 WO2001074386 A3 WO 2001074386A3 US 0108968 W US0108968 W US 0108968W WO 0174386 A3 WO0174386 A3 WO 0174386A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- viruses
- cold
- equine influenza
- influenza virus
- influenza
- Prior art date
Links
- 241000283073 Equus caballus Species 0.000 title abstract 8
- 241000712461 unidentified influenza virus Species 0.000 title abstract 8
- 239000000203 mixture Substances 0.000 abstract 5
- 230000001225 therapeutic effect Effects 0.000 abstract 5
- 241000712431 Influenza A virus Species 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 239000012678 infectious agent Substances 0.000 abstract 3
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- 241000283086 Equidae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16164—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002403979A CA2403979A1 (en) | 2000-04-03 | 2001-03-21 | Cold-adapted equine influenza viruses |
JP2001572128A JP2003528925A (en) | 2000-04-03 | 2001-03-21 | Cold adapted equine influenza virus |
AU4930001A AU4930001A (en) | 2000-04-03 | 2001-03-21 | Cold-adapted equine influenza viruses |
DE60125736T DE60125736D1 (en) | 2000-04-03 | 2001-03-21 | COMPOSITIONS CONTAINING COLD ADAPTED HORSE INFLUENZA VIRUSES FOR THE TREATMENT OF EXISTING VIRUS INFECTIONS OF THE BREATHING SYSTEM |
AU2001249300A AU2001249300B2 (en) | 2000-04-03 | 2001-03-21 | Cold-adapted equine influenza viruses |
EP01922507A EP1267920B1 (en) | 2000-04-03 | 2001-03-21 | Compositions comprising cold-adapted equine influenza viruses for the treatment of existing viral infections of the respiratory system. |
US10/239,972 US7029903B2 (en) | 2000-04-03 | 2001-03-21 | Cold-adapted equine influenza viruses |
US11/332,989 US20060121521A1 (en) | 2000-04-03 | 2006-01-17 | Cold-adapted equine influenza viruses |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19432500P | 2000-04-03 | 2000-04-03 | |
US60/194,325 | 2000-04-03 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/332,989 Continuation US20060121521A1 (en) | 2000-04-03 | 2006-01-17 | Cold-adapted equine influenza viruses |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001074386A2 WO2001074386A2 (en) | 2001-10-11 |
WO2001074386A3 true WO2001074386A3 (en) | 2002-05-23 |
Family
ID=22717146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/008968 WO2001074386A2 (en) | 2000-04-03 | 2001-03-21 | Cold-adapted equine influenza viruses |
Country Status (8)
Country | Link |
---|---|
US (2) | US7029903B2 (en) |
EP (1) | EP1267920B1 (en) |
JP (1) | JP2003528925A (en) |
AT (1) | ATE350056T1 (en) |
AU (2) | AU2001249300B2 (en) |
CA (1) | CA2403979A1 (en) |
DE (1) | DE60125736D1 (en) |
WO (1) | WO2001074386A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004003572A1 (en) * | 2004-01-23 | 2005-08-18 | Bavarian Nordic A/S | Monoparamunity inducers based on attenuated rabbit myxomaviruses |
US7572620B2 (en) | 2005-01-11 | 2009-08-11 | Wisconsin Alumni Research Foundation | H3 equine influenza A virus |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
EP2391713A1 (en) | 2009-01-30 | 2011-12-07 | The Board Of Regents For Oklahoma State University | Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs |
CN107375919B (en) | 2009-03-27 | 2022-07-29 | 台湾地区“中央研究院” | Methods and compositions for antiviral immunity |
KR20130018681A (en) * | 2010-03-10 | 2013-02-25 | 인터벳 인터내셔널 비.브이. | Method for protecting against disease caused by secondary pathogens |
TWI537385B (en) | 2010-11-04 | 2016-06-11 | 中央研究院 | Methods for producing virus particles with simplified glycosylation of surface proteins |
CN104411330B (en) * | 2012-05-31 | 2017-02-22 | 佐蒂斯有限责任公司 | Vaccination with canine respiratory coronavirus for protection against b. bronchiseptica infections |
JP6560056B2 (en) * | 2015-08-07 | 2019-08-14 | ウィスコンシン アルムニ リサーチ ファンデイション | H3 equine influenza A virus |
JP2018088928A (en) * | 2018-02-13 | 2018-06-14 | ウィスコンシン アルムニ リサーチ ファンデイション | H3 equine influenza a virus |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000009702A1 (en) * | 1998-08-13 | 2000-02-24 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3518347A (en) * | 1965-05-28 | 1970-06-30 | Inst Microbiologie Et D Hygien | Vaccine for equine influenza |
US3992522A (en) * | 1973-01-24 | 1976-11-16 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Temperature-sensitive recombinant mutant viruses and a process for producing same |
WO1983003546A1 (en) | 1982-04-16 | 1983-10-27 | Cornell Res Foundation Inc | Temperature sensitive reassortant viruses and a vaccine against equine influenza |
US4683137A (en) * | 1982-04-16 | 1987-07-28 | Cornell Research Foundation, Inc. | Temperature sensitive reassortant viruses and a vaccine against equine influenza |
GB8300467D0 (en) * | 1983-01-08 | 1983-02-09 | Wellcome Found | Equine influenza |
US4631191A (en) * | 1985-06-20 | 1986-12-23 | Biotechnology Research Partners, Ltd. | Methods and compositions useful in preventing equine influenza |
US4920213A (en) * | 1985-06-20 | 1990-04-24 | Biotechnology Research Partners, Ltd. | Method and compositions useful in preventing equine influenza |
US5149531A (en) * | 1990-06-27 | 1992-09-22 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza |
IL105456A (en) | 1992-04-21 | 1996-12-05 | American Home Prod | Attenuated respiratory syncytial virus vaccine compositions |
US5690937A (en) * | 1995-06-05 | 1997-11-25 | Aviron | Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene |
-
2001
- 2001-03-21 DE DE60125736T patent/DE60125736D1/en not_active Expired - Lifetime
- 2001-03-21 AU AU2001249300A patent/AU2001249300B2/en not_active Expired
- 2001-03-21 CA CA002403979A patent/CA2403979A1/en not_active Abandoned
- 2001-03-21 JP JP2001572128A patent/JP2003528925A/en active Pending
- 2001-03-21 AU AU4930001A patent/AU4930001A/en active Pending
- 2001-03-21 AT AT01922507T patent/ATE350056T1/en not_active IP Right Cessation
- 2001-03-21 EP EP01922507A patent/EP1267920B1/en not_active Expired - Lifetime
- 2001-03-21 WO PCT/US2001/008968 patent/WO2001074386A2/en active IP Right Grant
- 2001-03-21 US US10/239,972 patent/US7029903B2/en not_active Expired - Lifetime
-
2006
- 2006-01-17 US US11/332,989 patent/US20060121521A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000009702A1 (en) * | 1998-08-13 | 2000-02-24 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
Non-Patent Citations (2)
Title |
---|
MAYR A: "[Respiratory infectious diseases in horses]. Respiratorische Infektionskrankheiten beim Pferd.", TIERARZTLICHE PRAXIS. SUPPLEMENT, (1987) 2 1-4. REF: 0, 1987, XP001015771 * |
TIMONEY P J: "Equine influenza.", COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, vol. 19, no. 3, 1996, pages 205 - 211, XP001015825, ISSN: 0147-9571 * |
Also Published As
Publication number | Publication date |
---|---|
CA2403979A1 (en) | 2001-10-11 |
DE60125736D1 (en) | 2007-02-15 |
AU4930001A (en) | 2001-10-15 |
WO2001074386A2 (en) | 2001-10-11 |
US7029903B2 (en) | 2006-04-18 |
JP2003528925A (en) | 2003-09-30 |
EP1267920B1 (en) | 2007-01-03 |
AU2001249300B2 (en) | 2006-02-16 |
US20040223980A1 (en) | 2004-11-11 |
EP1267920A2 (en) | 2003-01-02 |
ATE350056T1 (en) | 2007-01-15 |
US20060121521A1 (en) | 2006-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE358722T1 (en) | COLD-ADAPTABLE HORSES INFLUENZA VIRUSES | |
WO2001060849A3 (en) | Cold-adapted equine influenza viruses | |
TW200730188A (en) | Vaccines and methods to treat canine influenza | |
WO2001074386A3 (en) | Cold-adapted equine influenza viruses | |
ATE451119T1 (en) | SUBUNITY VACCINE AGAINST RESPIRATORY SYNZYTIAL VIRUS | |
MXPA02004627A (en) | Vaccines for mycoplasma bovis. | |
DE60130998D1 (en) | RIBAVIRIN-CONTAINING VACCINE | |
WO2007098717A3 (en) | Chimeric vaccine antigens against classical swine fever virus | |
WO2007036735A3 (en) | Immunogenic agents againts burkholderia psudomallei and/or burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from burkholderia psuedomallei | |
WO2004043404A3 (en) | Process for designing inhibitors of influenza virus non-structural protein 1 | |
MXPA03009763A (en) | Foot and mouth disease virus vaccine. | |
WO1999053950A3 (en) | Live vaccines and methods of treatment therewith | |
WO2005084315A3 (en) | Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease | |
JP2003528925A5 (en) | ||
Dowling et al. | Cold-adapted equine influenza viruses | |
WO2007135420A3 (en) | Defective interfering virus | |
HUP9700975A2 (en) | Live attenuated rtx-producing bacteria of the family pasteurellaceae | |
YU65102A (en) | In ovo protection against infectious bronchitis | |
TW200503755A (en) | Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella | |
DK1132466T3 (en) | Chicken anemia virus with low pathogenicity | |
Thomson et al. | Foot and Mouth Disease in Southern Africa: Re-evaluation of the approach to control | |
WO2002081712A3 (en) | Artificial chromosomes comprising ehv sequences | |
NO20014372D0 (en) | Isolation and partial characterization of a novel antiprocferative component from human leukocytes | |
Bensaude et al. | 40. Interactions between Classical swine fever virus and host cells | |
Holliman | 38. Foot and mouth disease in Cumbria—a day in the life |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001249300 Country of ref document: AU Ref document number: 2403979 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001922507 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 572128 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10239972 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001922507 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001922507 Country of ref document: EP |